Prilenia Investigational Site (Site 017) — Boston, Massachusetts

Prilenia Investigational Site (Site 017) is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Prilenia Investigational Site (Site 017) has participated in 1 clinical trials.

Therapeutic areas: Huntington Disease.

Sponsors: Prilenia.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Prilenia Investigational Site (Site 017)?

Prilenia Investigational Site (Site 017) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Prilenia Investigational Site (Site 017) conducted?

Prilenia Investigational Site (Site 017) has 1 clinical trials on record. Their work covers Huntington Disease.

Is Prilenia Investigational Site (Site 017) accredited by Crixeo Health?

Prilenia Investigational Site (Site 017) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Prilenia Investigational Site (Site 017)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.